Get started
Author

Rebecca Kaufman

Observed names: Kaufman, Rebecca S., Rebecca S Kaufman, Rebecca S. Kaufman, Rebecca S. Kaufman (20367357)
ORCID: 0000-0001-8535-9730
Observed ORCID: 0000-0001-8535-9730
OpenAlex ID: A5024251842
OpenPBTA: The Open Pediatric Brain Tumor Atlas
2023 · Joshua A. Shapiro, Krutika S. Gaonkar, et al. · Cell Genomics · 69
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2024 · Liron D. Grossmann, Chia-Hui Chen, et al. · Cancer Discovery · 36
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival
2023 · Jung Kim, Zalman Vaksman, et al. · JNCI Journal of the National Cancer Institute · 31
PDF
Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants
2022 · Jennifer L Stundon, Heba Ijaz, et al. · Neuro-Oncology · 21
PDF
Lurbinectedin Inhibits the EWS–WT1 Transcription Factor in Desmoplastic Small Round Cell Tumor
2022 · Jenna M. Gedminas, Rebecca Kaufman, et al. · Molecular Cancer Therapeutics · 21
PDF
AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification
2024 · Jung Kim, Ammar S Naqvi, et al. · Bioinformatics · 17
PDF
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma
2024 · Jennifer Jess, Katie M. Sorensen, et al. · Clinical Cancer Research · 13
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition
2025 · Peter N. Fiorica, Lisa Golmard, et al. · Clinical Cancer Research · 7
Germline pathogenic variants in 786 neuroblastoma patients
2023 · Jung Kim, Zalman Vaksman, et al. · medRxiv · 6
PDF
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma
2025 · Marie Ménard, Hiroyuki Yoda, et al. · The Journal of Experimental Medicine · 5
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription
2026 · Rebecca Kaufman, Guillermo Flores, et al. · Nature Communications · 2
Data underlying OpenPBTA Manuscript Figures and Molecular Alterations
2023 · Shapiro, Joshua A., Gaonkar, Krutika S., et al. · Zenodo (CERN European Organization for Nuclear Research) · 1
Detecting Selection on Segregating Gene Duplicates in a Population
2021 · Tristan L. Stark, Rebecca S. Kaufman, et al. · Journal of Molecular Evolution · 1
PDF
Abstract 3030: Heritability of cancer predisposition gene mutations in 556 neuroblastoma patients with paired parental DNA whole genome sequences
2021 · Emily Blauel, Zalman Vaksman, et al. · Cancer Research · 1
Abstract C008: Expanding the spectrum of pathogenic germline BARD1 variants in children with neuroblastoma
2026 · Elizabeth M. Gonzalez, Rebecca S. Kaufman, et al. · Cancer Research
Figure S6 from Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2026 · Liron D. Grossmann, Chia-Hui Chen, et al.
Figure S3 from Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2026 · Liron D. Grossmann, Chia-Hui Chen, et al.
Figure S1 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition
2026 · Peter N. Fiorica, Lisa Golmard, et al.
Figure S3 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition
2026 · Peter N. Fiorica, Lisa Golmard, et al.
Supplementary Table S3 from Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2026 · Liron D. Grossmann, Chia-Hui Chen, et al.
Figure S4 from Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2026 · Liron D. Grossmann, Chia-Hui Chen, et al.
Figure S5 from Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2026 · Liron D. Grossmann, Chia-Hui Chen, et al.
Supplementary Table S2 from Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2026 · Liron D. Grossmann, Chia-Hui Chen, et al.
Figure S2 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition
2026 · Peter N. Fiorica, Lisa Golmard, et al.
Figure S5 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition
2026 · Peter N. Fiorica, Lisa Golmard, et al.
Works count: 89
Citation count: 231
H-index: 7
I10-index: 7
Year
Topic
Type